StoneCo Ltd (STNE) concluded trading on Wednesday at a closing price of $9.13, with 4.42 million shares of worth about $40.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.34% during that period and on March 12, 2025 the price saw a loss of about -0.54%. Currently the company’s common shares owned by public are about 278.03M shares, out of which, 246.59M shares are available for trading.
Stock saw a price change of -1.62% in past 5 days and over the past one month there was a price change of -3.39%. Year-to-date (YTD), STNE shares are showing a performance of 14.55% which decreased to -45.26% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $7.72 but also hit the highest price of $17.93 during that period. The average intraday trading volume for StoneCo Ltd shares is 6.12 million. The stock is currently trading -4.09% below its 20-day simple moving average (SMA20), while that difference is up 1.55% for SMA50 and it goes to -17.46% lower than SMA200.
StoneCo Ltd (NASDAQ: STNE) currently have 278.03M outstanding shares and institutions hold larger chunk of about 71.24% of that.
The stock has a current market capitalization of $2.71B and its 3Y-monthly beta is at 2.11. PE ratio of stock for trailing 12 months is 7.46, while it has posted earnings per share of $1.22 in the same period. Its PEG reads 0.37 and has Quick Ratio of 1.42 while making debt-to-equity ratio of 0.66. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for STNE, volatility over the week remained 4.74% while standing at 4.18% over the month.
Stock’s fiscal year EPS is expected to rise by 42.71% while it is estimated to increase by 2.97% in next year. EPS is likely to shrink at an annualized rate of 20.27% for next 5-years, compared to annual growth of 23.53% made by the stock over the past 5-years.
Coverage by Morgan Stanley stated StoneCo Ltd (STNE) stock as an Underweight in their note to investors on September 05, 2024, suggesting a price target of $7 for the stock. On July 08, 2024, UBS Upgrade their recommendations, while on June 06, 2024, JP Morgan Upgrade their ratings for the stock with a price target of $20. Stock get a Neutral rating from UBS on February 01, 2024.
